Essential Science Provides CMC Support To NASDAQ-Quoted US Biopharma
Undisclosed, US and Edzell UK 15 Feb 2007 - Essential Science Ltd sign agreement with NASDAQ-quoted US Biopharmaceutical Company.
Essential Science has signed an agreement with a US-based Biopharmaceutical company to provide expert CMC support that will enhance the effectiveness of their development activities. The company currently has a number of CNS clinical development projects at various stages of their pipeline.
About Essential Science
Essential Science Ltd supports technology clients in the development and exploitation of new technologies across the Life Science marketplace. As the number of available technologies grows and client success becomes increasingly dependent on the identification and exploitation of the right technologies, its experienced team, supported by an extensive associate network, is focused on establishing the partnerships that bring client technologies to market faster and more effectively.
Enquiries
::
Neil Murray
::
+44 1356 648941
::
neil@essentialscience.co.uk
Date
::
Thursday 15 February 2007
|